SOLT is trading at $57.86, up 2.19% in pre-market, with no confirmed cause for the rebound.
- No clear SOLT-specific announcement or overnight catalyst was identified in available coverage.
- SOLT targets twice Solanaβs daily performance. Coverage reported Solana fell 4.3% on October 22 amid risk-off pressure, but that does not explain this pre-market rise.
- Major U.S. index indications are mixed, providing no clear explanation for SOLTβs gain.